Drug manufacturers use FDA, patent strategies to keep insulin prices high
An analysis of U.S. Food and Drug Administration (FDA) and patent records revealed how manufacturers have extended periods of market exclusivity for brand-name insulin products
2023-11-16
(Press-News.org) Over the last four decades, insulin manufacturers have extended their periods of market exclusivity on brand-name insulin products by employing several strategies, including filing additional patents on their products after FDA approval and obtaining many patents on delivery devices for their insulin products. That is the conclusion of a new analysis of FDA and patent records carried out by William Feldman of Brigham and Women’s Hospital, USA, and colleagues, and published November 16th in the open access journal PLOS Medicine.
Insulin is the primary, life-saving treatment for type 1 and some type 2 diabetes but remains costly in the US even though it was discovered more than a century ago. A 2021 Congressional report found that for decades, the three major manufacturers of insulin continuously raised prices, often in tandem with one another. These high prices are additionally sustained by patents and regulatory exclusivity that limit competition on brand-name products. Patents are government-granted monopolies that last 20 years and the Food and Drug Administration (FDA) cannot approve generic versions of drugs for marketing until patents have expired.
In the new study, researchers used publicly available U.S. FDA and patent data to track all insulin products approved in the U.S. from 1986 to 2019. During the study period, the FDA approved 56 brand-name insulin products.
The researchers found that protection on insulin was enhanced by patents obtained after FDA approval, which lengthened expected market exclusivity by a median of 6 years. Moreover, many patents were on the insulin delivery devices rather than the drugs themselves. In two-thirds of drug-device combinations, the device patents were the last to expire; these last-to-expire device patents extended protection for a median of 5.2 years. Overall, manufacturers secured a median of 16 years of protection on their insulin products through patents and exclusivities, surpassing the median of 14 years observed in other studies of top-selling small-molecule drugs. The insulin lines with the longest periods of expected protection from the first product approved to last-to-expire patent was Lantus (32.9 years), followed by Novolog (32.3 years) and Novolog 70/30 (30.9 years).
“Policy reforms are needed to promote timely competition in the pharmaceutical market and ensure that patients have timely access to drugs at fair prices,” the authors say.
Feldman adds, “Our study highlights how manufacturers have listed an increasing number of patents on insulin products over the years. These patents can delay competition and keep prices high for patients.”
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004309
Citation: Olsen A, Beall RF, Knox RP, Tu SS, Kesselheim AS, Feldman WB (2023) Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019. PLoS Med 20(11): e1004309. https://doi.org/10.1371/journal.pmed.1004309
Author Countries: United States, Canada
Funding: see manuscript
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-11-16
Swedish people with the lowest incomes utilize primary and outpatient care on par with those with the highest incomes despite having significantly higher mortality rates, according to a new study published November 16th in the open access journal PLOS Medicine by Pär Flodin of Karolinska Institutet, Sweden, and colleagues.
Socioeconomic differences in healthcare utilization have persisted in modern welfare states even with universal healthcare. In recent decades, Sweden has witnessed a rise in income inequalities, accompanied by shifts in the sociodemographic composition of the population ...
2023-11-16
A new study published this week in Science challenges the notion that only humans are capable of forming strong and strategic cooperative relationships and sharing resources across non-family groups. Researchers from Harvard University and the German Primate Center examined the pro-social behavior of bonobos (Pan paniscus), one of humanity’s closest living relatives, finding that their cooperation extends beyond one’s own group to societal cooperation with different groups.
Studying humans' two closest living relatives, chimpanzees and bonobos, can help reconstruct ancestral human traits like cooperation and conflict. Despite living in similar ...
2023-11-16
Cells contain molecular machinery that targets and disposes of unwanted proteins to maintain homeostasis. Scientists think that with the help of “matchmaker” molecules called molecular glue degraders, this machinery could be hijacked to control proteins involved in diseases like cancer. But only a few of these glue degraders have been discovered so far—and mostly by chance.
Zuzanna Kozicka, as a Ph.D. student at Friedrich Miescher Institute in Basel, Switzerland, embarked on a deliberate search for these glues with her team and identified a novel class of molecular glue degraders with more than 40 chemically diverse members. Kozicka, who is now a postdoctoral ...
2023-11-16
Researchers have developed a solid-state electrocaloric cooling device that can generate a 20 kelvin temperature difference with high efficiency, according to a new study. The findings show that electrocaloric cooling can compete with other solid-state cooling strategies and offer a promising alternative to environmentally unfriendly vapor compression cooling. Cooling devices, including air-conditioning and heat pump systems, are estimated to consume roughly 20% of global electricity. Most of these systems operate through vapor-compression technologies, which are relatively inefficient and require environmentally harmful fluorinated refrigerants. Cooling through solid-state electrocaloric ...
2023-11-16
The same bundle of non-living filaments that mussels use to anchor themselves within their environment – to withstand crushing waves, for example – can also be jettisoned on demand. Mussels create this quick-release interface, a new study finds, by way of a neurochemically-mediated junction, where billions of motile cilia hold fast to interlinked biopolymer sheets. "[The study’s] findings could be informative about how nonliving materials can be dynamically interfaced with living tissue, as in the case of detachable biosensors and medical implants," write Guoqing Pan and Bin Li in a related ...
2023-11-16
New biosensors have helped reveal the activity of neuropeptides in the brain, researchers report, providing novel tools for studying the release, function, and regulation of these crucial signaling molecules in vivo. According to the study, the approach has the potential to address key questions regarding neuropeptides and their roles in health and disease. In the brain, neuropeptides are key signaling molecules in the body that regulate many critical physiological functions, including digestion, metabolism, sleep, and higher ...
2023-11-16
Jessica Kendall-Bar, who received her Ph.D. in ecology and evolutionary biology last year from UC Santa Cruz with co-advisors Terrie Williams and Dan Costa, was named a recipient of the prestigious Science & SciLifeLab Prize for Young Scientists for her research on elephant seal sleep habits while they are at sea.
The Science & SciLifeLab Prize is an international prize awarded by the American Association for the Advancement of Science (AAAS) and the journal Science to early career scientists for their outstanding thesis research in the life sciences. As ...
2023-11-16
CAMBRIDGE, MA -- Every cell in the human body contains the same genetic instructions, encoded in its DNA. However, out of about 30,000 genes, each cell expresses only those genes that it needs to become a nerve cell, immune cell, or any of the other hundreds of cell types in the body.
Each cell’s fate is largely determined by chemical modifications to the proteins that decorate its DNA; these modification in turn control which genes get turned on or off. When cells copy their DNA to divide, however, they lose half of these modifications, leaving the question: How do cells maintain the memory of what kind of cell they are supposed ...
2023-11-16
The University of Liverpool’s Department of Chemistry has been awarded a prestigious Queen’s Anniversary Prize in recognition of its pioneering research and innovation work to address global challenges and benefit society.
The Queen’s Anniversary Prize is the highest national honour in Higher Education. It is awarded in recognition of world-class excellence and achievement to a small selection of UK institutions every two years.
The Department of Chemistry at the University of Liverpool carries out world-leading research that pushes forward the frontiers of ...
2023-11-16
Personalized deep-learning models can enable artificial intelligence chatbots that adapt to understand a user’s accent or smart keyboards that continuously update to better predict the next word based on someone’s typing history. This customization requires constant fine-tuning of a machine-learning model with new data.
Because smartphones and other edge devices lack the memory and computational power necessary for this fine-tuning process, user data are typically uploaded to cloud servers where the model is updated. But data ...
LAST 30 PRESS RELEASES:
[Press-News.org] Drug manufacturers use FDA, patent strategies to keep insulin prices high
An analysis of U.S. Food and Drug Administration (FDA) and patent records revealed how manufacturers have extended periods of market exclusivity for brand-name insulin products
